Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_assertion type Assertion NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_head.
- NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_assertion description "[Of the primary tumors, 73 of 90 (81%) displayed promoter hypermethylation in at least one of the genes studied: 17% (15 of 90) at p16 (CDKN2A); 16% (14 of 90) at O(6)-methylguanine-DNA-methyltransferase; 8% (7 of 90) at GSTP1; 72% (65 of 90) at APC; and 17% (15 of 90) at DAPK.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_provenance.
- NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_assertion evidence source_evidence_literature NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_provenance.
- NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_assertion SIO_000772 12684406 NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_provenance.
- NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_assertion wasDerivedFrom befree-2016 NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_provenance.
- NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_assertion wasGeneratedBy ECO_0000203 NP390222.RAWTAv7vFs0nCoguCW8VDU2SI9HbRyKhSH21oTJmaAw6k130_provenance.